Initial development of an evidence base for personalized medicine’s translation to clinical practice and health policy

Author： Phillips Kathryn A   Van Bebber Stephanie L   Issa Amalia M  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.3, Iss.4, 2006-11, pp. : 411-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized medicine in bipolar disorder: how can we overcome the barriers to clinical translation?

By Squassina Alessio   Pisanu Claudia  

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 765-768

Future Medicine

Access to resources Recommend Favorite

Personalized medicine: a competitor or an upgrade of evidence-based medicine?

By Bereczki Daniel  

Personalized Medicine, Vol. 9, Iss. 2, 2012-03 ,pp. : 211-221

Future Medicine

Access to resources Recommend Favorite

Translation of psychoneuroimmunology into personalized medicine: a systems biology perspective

By Yan Qing  

Personalized Medicine, Vol. 8, Iss. 6, 2011-11 ,pp. : 641-649

Future Medicine

Access to resources Recommend Favorite

Innovation in personalized medicine: BiDil® as a case study for integrating clinical and policy developments

By Issa Amalia M   Todd Weiss L   Tufail Waqas   Phillips Kathryn A   Van Bebber Stephanie L  

Personalized Medicine, Vol. 3, Iss. 4, 2006-11 ,pp. : 421-427

Future Medicine

Access to resources Recommend Favorite

Role of the clinical laboratory in personalized medicine: challenges and opportunities

By Langley Michael   Weck Karen E  

Personalized Medicine, Vol. 5, Iss. 1, 2008-01 ,pp. : 1-4

Future Medicine

Access to resources Recommend Favorite